Vinpocetine and stroke
What 2 graded rows on vinpocetine agree on for stroke, and where they differ. Counted side by side, never averaged.
Consensus finder Rows from the Vinpocetine page, reviewed Oct 21, 2026 How it decides
What the rows agree on
Each block and row is one graded row from the Vinpocetine page, with its PubMed record.
Your question
Vinpocetine and stroke
2 rows · 900 peopleSplit. 1 row found an improvement and 1 found no difference.
- CGrade C× 1
- DGrade D× 1
- Rows
- 2
- Trials
- 6
- People
- 900
- Pooled reviews may count some twice
Where they differ
From the rowsThe best-graded row, grade C, is a meta-analysis of 837 people (2022) and found an improvement.
The row that found an improvement was larger: 837 people, against 63 people for the row that found no difference.
The row that found an improvement is newer (2022) than the row that found no difference (2008).
The best grade is C among the row that found an improvement, and D among the row that found no difference.
The rows
1 improved · 1 no difference- CGrade CDeath or significant disability after acute ischaemic stroke · Improved
Meta-analysis, 4 studies · n 837 · 2022 · Patients with acute ischaemic stroke (4 placebo-controlled trials)
Not stated in the abstract · 1 and 3 months follow-up
Death or significant disability was lower than with placebo at 1 month (RR 0.80) and 3 months (RR 0.67); the authors say evidence is not enough to show lower deaths and call for larger trials.
Row on the Vinpocetine page · PubMed 35488169 (opens PubMed)
- DGrade DDeath or dependency after acute ischaemic stroke · No difference
Systematic review, 2 studies · n 63 · 2008 · People within 14 days of acute ischaemic stroke (2 trials)
Not stated in the abstract · 1 and 3 months follow-up
Death or dependency did not differ from placebo; confidence intervals were wide, so neither benefit nor harm could be ruled out.
Row on the Vinpocetine page · PubMed 18253980 (opens PubMed)